Explore more publications!

The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on March 17, 2026

Nuvini Announces Extension of Earnout Restructuring Deadline
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
LATAM Airlines Group y gategroup amplían su acuerdo plurianual para elevar la gastronomía a bordo
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
Terra Balcanica Intercepts 607 g/t Ag Eq. Over 3.0 m and 670 g/t Ag Eq. Over 3.9 m At Cumavici in Bosnia and Herzegovina
Neuroscientist from US-Mexico border dismantles science's class problem from the inside
SK pharmteco gibt den erfolgreichen Abschluss einer FDA-Inspektion der Produktionsstätte für niedermolekulare Wirkstoffe in La Porte, Texas, bekannt
SK pharmteco annonce le succès de l’inspection de son site de fabrication de petites molécules par la FDA, à La Porte, au Texas
SK pharmteco, 텍사스 라포트 소분자 생산시설 FDA 실사 성공적 완료 발표
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
SK pharmteco Announces Successful FDA Inspection of Small Molecule Manufacturing Facility in La Porte, Texas
Agoyu Founder Bill Mulholland Named 2026 Supply & Demand Chain Executive Pros to Know Award Winner
Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026
GoldHaven Advances Copeçal Gold Project Following Initial Drilling; Phase 2 Program Planned at West Target

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions